Rhythm posts late-stage trial win for lead asset against rare form of obesity
Rhythm Pharma (RYTM) stock in focus as lead asset setmelanotide hits the main goal in a Phase 3 trial for hypothalamic ...
Shades Of Smoot-Hawley: Depression Feared
At the end of last week, there was much talk about Black Monday and today it is here. Various circuit breakers kicked in as ...
S&P 500 Index Elliott Wave technical analysis [Video]
The S&P 500 is currently positioned in a counter-trend structure, moving through navy blue wave C, which is part of the larger gray wave 2. The preceding navy blue wave B appears to have ended, paving ...